RxDoctor Payments Data
★ My doctorsLook up a doctor →

Kenneth Fan, MD

Plastic Surgery · Washington, DCNPI 1144586355

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $38,410 of the $52,638 with a category attached, or 73.0%. Integra Lifesciences Corporation accounts for 88.0% of it on its own, with 17 other manufacturers making up the rest. Among plastic surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$52,638in general payments, 2019–2025

Across 84 payments — averaging $626.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$46K
  • Axogen$3K
  • RTI Surgical, Inc$2K
  • Mentor Worldwide LLC$457
  • AbbVie$323
  • Baxter Healthcare$160
  • plus $788 from 12 others
$106,203in research payments, 2019–2025

Across 5 payments — averaging $21,241 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Solventum Corporation$60K
  • Mentor Worldwide LLC$39K
  • Butterfly Network, Inc.$7K

What the payments were for

  • Consulting fees$38,41073%
  • Speaking & faculty fees$2,3204%
  • Travel & lodging$6,61513%
  • Food & beverage$3,7407%
  • Other$1,5533%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Integra Lifesciences Corporation42$46,299
Axogen11$3,110
RTI Surgical, Inc1$1,500
Mentor Worldwide LLC8$457
AbbVie(2 entities)4$323
Baxter Healthcare2$160
Innovation Technologies Inc2$154
Stryker2$132
Endomagnetics Ltd1$110
Access Pro Medical, LLC1$100
Motiva USA, LLC1$72
Regeneron Healthcare Solutions, Inc.2$56
TELA Bio, Inc.2$39
Acera Surgical, Inc.1$36
Pacira Pharmaceuticals Incorporated1$29
Smith+Nephew1$22
Solventum Corporation1$21
Biotissue Holdings Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,638 in reported general payments places this provider in the 90th percentile of 34 plastic surgery providers in District of Columbia.

See all plastic surgery providers in District of Columbia →

Medicare billing

Part B allowed, 2024
$201,492
Medicare patients
109
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic surgery in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →